Trademark: 79336171
Word
CHIMAGENTS
Status
Registered
Status Code
700
Status Date
Tuesday, September 26, 2023
Serial Number
79336171
Registration Number
7171768
Registration Date
Tuesday, September 26, 2023
Mark Type
4000
Filing Date
Wednesday, December 8, 2021
Published for Opposition
Tuesday, July 11, 2023

Trademark Owner History
OPEN ORPHAN PLC - Original Registrant

Classifications
5 Pharmaceuticals, namely, pharmaceuticals for the treatment of skin disorders, dermatological conditions, respiratory diseases and asthma, cancer, baldness, heart disease, cardiovascular disorders, allergies, muscle injuries and disorders, erectile dysfunction, viral diseases, hormonal disorders, infectious diseases, bone diseases, stretch marks, eye diseases and eye conditions, gastro-intestinal diseases, psychiatric diseases and disorders, immune system related diseases and disorders, insomnia, neuropathic pain, sinus congestion, blood disorders, pain, inflammation, obesity and cognitive disorders, ocular diseases or disorders, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetespyschotropics, antihelmintics, lipid lowering agents; vaccines, reagents for medical use; medical and veterinary preparations for the diagnosis and treatment of infectious diseases; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; medical and surgical plasters; materials for dressings, namely, medical and surgical dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides
35 Advertising services, namely, advertising of pharmaceuticals, reagents for medical use, medical drugs and vaccines; advertising services relating to pharmaceuticals; business management in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business advisory services in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business administration in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial consultancy in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial intermediation services in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines, namely, connecting buyers and sellers in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; negotiating and concluding commercial transactions for others in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; providing business assistance in the field of pharmaceutical, reagents for medical use, medical drug and vaccine product commercialization; commercial lobbying services in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial information in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial management assistance in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; preparation of commercial reports for others in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; collection of commercial information relating to the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines into computer databases; provision of information concerning commercial sales relating to the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; compilation of business statistics and commercial information relating to the field of pharmaceuticals, medical drugs and vaccines; business management consultancy and advisory services relating to the field of pharmaceuticals, medical drugs and vaccines; business management of reimbursement programmes for others relating to the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business administration of medication reimbursement programs and services; provision of an online marketplace for buyers and sellers of pharmaceuticals, reagents for medical use, medical drugs and vaccines; sales promotion of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business opportunity promotion of pharmaceuticals, reagents for medical use, medical drugs and vaccines; promotion services being marketing services; promotional and advertising services; promoting the sale of goods and services of others through promotional events in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; database management relating to pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical trials; retail and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services relating to medical instruments and devices, pharmaceuticals, reagents for medical use, drugs and vaccines
42 Scientific and technological services, namely, research relating to pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical trials, and design relating thereto; industrial analysis and industrial research services in the field of pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical trials; preparation of technical reports relating to pharmaceuticals, reagents for medical use, drugs and vaccines, namely, technical writing; technical research relating to pharmaceuticals, reagents for medical use, medical drugs and vaccines; providing scientific information in the field of medical disorders and their treatment; medical and pharmacological research services; medical research relating to pharmaceuticals, reagents for medical use, medical drugs and vaccines; scientific research for medical purposes, namely, medical research; provision of scientific information and data relating to medical and veterinary research and development; research and development in the field of biotechnology; biotechnology testing, namely consumer product testing in the field of biotechnology; testing of pharmaceuticals; technical testing services relating to pharmaceuticals, reagents for medical use, medical drugs and vaccines; testing, authentication and quality control of pharmaceuticals, reagents for medical use, medical drugs and vaccines; consultancy relating to biotechnology; medical laboratory services; product design and development in the field of medical technology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical trials, namely, scientific research in the nature of conducting clinical trials for others; research and development of vaccines and medicines; drug discovery services; pharmaceutical drug development services; pharmaceutical research services; pharmaceutical product evaluation; pharmaceutical research and development services

Trademark Events
Jan 22, 2024
Final Decision Transaction Processed By Ib
Dec 29, 2023
Final Disposition Notice Sent To Ib
Dec 29, 2023
Final Disposition Processed
Dec 26, 2023
Final Disposition Notice Created, To Be Sent To Ib
Sep 26, 2023
Notice Of Registration Confirmation Emailed
Sep 26, 2023
Registered-Principal Register
Sep 11, 2023
Notification Of Possible Opposition - Processed By Ib
Aug 23, 2023
Notification Of Possible Opposition Sent To Ib
Aug 23, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Jul 11, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 11, 2023
Published For Opposition
Jul 10, 2023
Notification Processed By Ib
Jun 20, 2023
Notification Of Possible Opposition Sent To Ib
Jun 21, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 21, 2023
Notification Of Notice Of Publication E-Mailed
Jun 7, 2023
Approved For Pub - Principal Register
May 24, 2023
Teas/Email Correspondence Entered
May 24, 2023
Correspondence Received In Law Office
May 24, 2023
Teas Response To Office Action Received
Dec 22, 2022
Refusal Processed By Ib
Nov 26, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Nov 26, 2022
Refusal Processed By Mpu
Sep 20, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Sep 19, 2022
Non-Final Action Written
Sep 16, 2022
Assigned To Examiner
Mar 29, 2022
Application Filing Receipt Mailed
Mar 24, 2022
New Application Office Supplied Data Entered
Mar 17, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24